Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126281541 | 12628154 | 1 | I | 20160725 | 20160808 | 20160808 | EXP | PL-APOTEX-2016AP010179 | APOTEX | LITWIN T, DZIEZYC K, KARLINSKI M, SZAFRANSKI T, CZLONKOWSKA A.. PSYCHIATRIC DISTURBANCES AS A FIRST CLINICAL SYMPTOM OF WILSON^S DISEASE - CASE REPORT.. PSYCHIATR-POL. 2016;50(2):337-344 | 26.00 | YR | M | Y | 0.00000 | 20160808 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126281541 | 12628154 | 1 | PS | APOTIAPINA | QUETIAPINE | 1 | Unknown | Y | 90960 | TABLET | |||||||||
| 126281541 | 12628154 | 2 | SS | OLANZAPINE APOTEX | OLANZAPINE | 1 | Unknown | 15 MG, PER 24 HOURS | Y | 0 | 15 | MG | TABLET | ||||||
| 126281541 | 12628154 | 3 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | Y | 0 | ||||||||||
| 126281541 | 12628154 | 4 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 1500 MG/24H | 0 | 1500 | MG | ||||||||
| 126281541 | 12628154 | 5 | SS | CLORAZEPATE | CLORAZEPATE DIPOTASSIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126281541 | 12628154 | 6 | SS | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 | |||||||||
| 126281541 | 12628154 | 7 | C | MIANSERIN | MIANSERIN | 1 | Unknown | AT NIGHT | U | U | 0 | 5 | MG | QD | |||||
| 126281541 | 12628154 | 8 | C | MIANSERIN | MIANSERIN | 1 | U | U | 0 | ||||||||||
| 126281541 | 12628154 | 9 | C | ZINC | ZINCINC CHLORIDE | 1 | Unknown | 180 MG, PER 24 HOUR | U | U | 0 | 180 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126281541 | 12628154 | 1 | Mania |
| 126281541 | 12628154 | 2 | Mania |
| 126281541 | 12628154 | 3 | Mania |
| 126281541 | 12628154 | 4 | Mania |
| 126281541 | 12628154 | 5 | Mania |
| 126281541 | 12628154 | 6 | Mania |
| 126281541 | 12628154 | 7 | Depression |
| 126281541 | 12628154 | 8 | Initial insomnia |
| 126281541 | 12628154 | 9 | Hepato-lenticular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126281541 | 12628154 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126281541 | 12628154 | Drug ineffective | |
| 126281541 | 12628154 | Dysarthria | |
| 126281541 | 12628154 | Dyskinesia | |
| 126281541 | 12628154 | Dysphagia | |
| 126281541 | 12628154 | Neurological decompensation | |
| 126281541 | 12628154 | Postural tremor | |
| 126281541 | 12628154 | Salivary hypersecretion | |
| 126281541 | 12628154 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |